Kerry Stokes’ Media Executives and Their Interest in Orthocell
Seven West Media shows a strong focus on the ASX medtech company Orthocell. This Perth-based firm, publicly traded on the ASX, specializes in cell regeneration therapies.
Orthocell was established in 2007 as a spin-out from the University of Western Australia. Its market capitalization fluctuates around $300 million and has increased by about 80% over the past year, marking impressive growth.
Despite these developments, Orthocell remains one of many smaller medtech companies listed on the ASX.
"Most people wouldn’t have heard of Orthocell. It’s a Perth-based, ASX-listed medtech that makes cell regeneration therapies."
Subscribe to get access to 5 free articles per month and follow topics, people, and companies relevant to your interests.
Summary: Seven West Media executives are keenly interested in Orthocell, a growing Perth-based medtech firm with notable market gains and potential in cell regeneration therapies.